Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
Jamie N. Anastas(Boston Children's Hospital), Barry M. Zee(Boston Children's Hospital), Jay H. Kalin(Harvard University), Mirhee Kim(New York University), Robyn Guo(Duke University), Sanda Alexandrescu(Boston Children's Hospital), Andrés Blanco(University of Pennsylvania), Stefanie Giera(Sanofi (United States)), Shawn Gillespie(Center for Cancer Research), Jayanta Das(University of North Carolina Health Care), Muzhou Wu(Boston University), Sarah E. Nocco(Boston University), Dennis M. Bonal(Imaging Center), Quang‐Dé Nguyen(Dana-Farber Cancer Institute), Mario L. Suvà(Massachusetts General Hospital), B Bernstein(Harvard University), Rhoda M. Alani(Boston University), Todd R. Golub(Broad Institute), Philip A. Cole(Harvard University), Mariella G. Filbin(Dana-Farber Cancer Institute), Yang Shi(Boston Children's Hospital)
Cited by 189Open Access